Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

ScreenIn3D takes home ELRIG award
April 2020
SHARING OPTIONS:

LIVERPOOL, U.K.—The ELRIG Drug Discovery 2019 conference, held late last year, saw ScreenIn3D, a partner of AMSBIO, receive the ELRIG Prize for Innovation in Drug Discovery. ScreenIn3D's screening service offers customers a combination of microfluidics and 3D cell culture to enable the study of drugs or drug combinations on a variety of cell and tissue types.
 
Steve Rees, ELRIG chairman and vice president of the Discovery Biology operation at AstraZeneca, said, “We are very proud to present our 2019 Innovation Award to ScreenIn3D. They have developed a fantastic technology which has direct application in target discovery including screening CRISPR libraries to identify novel drug targets, combination screening in discovery and determining treatment regimes in the clinic. These attributes were very fitting to this award and demonstrates true innovation within the Drug Discovery space. We wish ScreenIn3D much continued success and look forward to seeing them at many more ELRIG events.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.